Pulse Therapeutics, a medical device startup, has raised $100 million in funding to develop innovative solutions for treating various medical conditions, including cardiovascular disease and diabetes.
Medical Device Innovation
Pulse Therapeutics' cutting-edge approach to medical device development has resulted in an 80% success rate in clinical trials, making its solutions highly promising for patients and healthcare providers.
Pulse Therapeutics has filed 15 patents for its medical devices.
'We're dedicated to creating life-changing medical devices that improve patient outcomes,' said Dr. David Kim, CEO of Pulse Therapeutics.